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Abstract 
Developing sensitive, specific and fast assays to detect and quantify cancer biomarkers 
at low concentration permit early stage diagnosis of cancer and to improve the survival 
rate. Many kinds of nanomaterials have been applied to break the limitations of 
conventional bioassays so as to offer high sensitivity, simplicity and at lower cost. The 
current development of nanoparticle based in-vitro diagnostics tests, such as paper-
based testing strips using gold nanoparticles, remain as being indicative rather than 
being quantitative. To fill the gap between lab based quantitative assays and techniques 
for point of care testing, smartphones will play an essential role. This takes the 
advantage of build-in optics and electronics suitable for data acquisition, quantification 
and communication. But this still requires the biochemistry methods to be more stable, 
selective and quantitative, particularly suitable for small volume of samples after 
minimum level of preparations.  
This thesis explores a new class of fluorescent probes and detection methods to bridge 
this gap. The new probes are rare earth doped upconversion nanoparticles (UCNPs) 
with high fluorescent intensity and negligible background noise. To improve the 
stability and selectivity of UCNPs, two techniques have been explored. Phage display 
has been employed to select antibodies that can bind to UCNPs surface forming more 
stable and biocompatible upconversion nanoprobe; bispecific antibodies are used to 
avoid chemical reaction in the bioconjugation step and deactivation of antibody 
bioconjugated to UCNPs so that the upconversion nanoprobes can have higher binding 
efficiency to the cancer biomarker. To meet the requirements of simple and quantitative 
point of care testing, highly rare earth doped UCNPs with hundreds to thousands of 
emitters have been introduced to essentially amplify the signal strength so that 
smartphone can read and quantify the prostate cancer biomarkers resulted in a paper 
based strip sensor; single nanoparticle image system has been applied to reach a single 
molecule level sensitivity for detecting prostate cancer biomarkers in sub-microliter 
samples. 
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 Key words: in-vitro diagnosis, cancer detection, upconversion nanoparticles, phage 
display, bispecific antibody, lateral flow strip, single-molecule detection. 
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